Brand family
Steglujan
Ertugliflozin pidolate and Sitagliptin and Ertugliflozin and Sitagliptin · Merck Sharp & Dohme
European UnionUnited States
- Presentations
- 2
- Markets
- 2
Steglujan is a brand of Ertugliflozin pidolate and Sitagliptin and Ertugliflozin and Sitagliptin marketed by Merck Sharp & Dohme, with 2 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ertugliflozin pidolate and Sitagliptin, Ertugliflozin and Sitagliptin
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 15 mg/100 mg tablet, 5 mg/100 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Steglujan 15 mg/100 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Steglujan 5 mg/100 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Steglujan
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.